Molluscum contagiosum

31st July 2015 by NASGP

Molluscum contagiosum

molluscumUntil now, the best treatment was to do nothing, but could a new drug, MolluDab, offer a cure? This DTB article reviews the evidence (DTB 2014;52(10):110).

MolluDab is 5% potassium hydroxide solution applied twice daily with a dabber. An inflammatory response should occur after 4-6d with lesions disappearing over the next 1-5w. It is available over the counter (OTC) and on prescription (except in Scotland). The RRP is £24.30 for 2ml! The main side effect is stinging/burning, with redness, itching, pain, ulceration, crusting and hyperpigmentation also reported.

The two main trials were tiny (<30 patients). The DTB review concluded there was no convincing effect and do not recommend prescribing it.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"The NASGP and the GP locum chambers that I'm in have provided invaluable assistance both before and through Covid-19 to me as a full-time GP locum. All aspects of locum work have been made easier as a result of membership and the chamber's support structure - from accessing work, to ensuring invoicing and documentation is all sorted, and access to other locums as peer support. Having a chamber manager means I feel more secure and can devote more of my energy on my clinical work."

Dr Richard Smith

Dr Richard Smith

See the full list of features within our NASGP membership plans

Membership